ASX - By Stock
|
CU6 |
Re:
Ann: World leading expert in copper-67 joins Clarity SAB
|
|
tonks306511
|
5 |
2.5K |
2 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
5
|
2.5K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Receipt of R&D Tax Incentive Payment
|
|
tonks306511
|
52 |
15K |
1 |
26/02/23 |
26/02/23 |
ASX - By Stock
|
52
|
15K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Why Analysts Believe RAC is “Highly Undervalued”
|
|
tonks306511
|
137 |
61K |
11 |
25/02/23 |
25/02/23 |
ASX - By Stock
|
137
|
61K
|
11
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
21K |
7.4M |
14 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
21K
|
7.4M
|
14
|
|
ASX - By Stock
|
PER |
Re:
Ann: Half Yearly Report and Accounts
|
|
tonks306511
|
34 |
8.4K |
3 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
34
|
8.4K
|
3
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
21K |
7.4M |
6 |
22/02/23 |
22/02/23 |
ASX - By Stock
|
21K
|
7.4M
|
6
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
21K |
7.4M |
9 |
22/02/23 |
22/02/23 |
ASX - By Stock
|
21K
|
7.4M
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Positive topline results from SAR-bisPSMA diagnostic trial
|
|
tonks306511
|
17 |
9.6K |
5 |
20/02/23 |
20/02/23 |
ASX - By Stock
|
17
|
9.6K
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Positive topline results from SAR-bisPSMA diagnostic trial
|
|
tonks306511
|
17 |
9.6K |
1 |
19/02/23 |
19/02/23 |
ASX - By Stock
|
17
|
9.6K
|
1
|
|
ASX - By Stock
|
BIG |
Re:
At last, someone is charged.
|
|
tonks306511
|
35 |
24K |
3 |
18/02/23 |
18/02/23 |
ASX - By Stock
|
35
|
24K
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
tonks306511
|
11K |
3.8M |
6 |
14/02/23 |
14/02/23 |
General
|
11K
|
3.8M
|
6
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Diagnostic prostate cancer trial reaches recruitment target
|
|
tonks306511
|
18 |
5.3K |
1 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
18
|
5.3K
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
21K |
7.4M |
3 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
21K
|
7.4M
|
3
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
21K |
7.4M |
3 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
21K
|
7.4M
|
3
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
21K |
7.4M |
5 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
21K
|
7.4M
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Positive topline results from SAR-bisPSMA diagnostic trial
|
|
tonks306511
|
17 |
9.6K |
2 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
17
|
9.6K
|
2
|
|
ASX - By Stock
|
DYL |
Re:
Ann: Strong Results From Tumas Definitive Feasibility Study
|
|
tonks306511
|
46 |
24K |
0 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
46
|
24K
|
0
|
|
ASX - By Stock
|
DYL |
Re:
Ann: Strong Results From Tumas Definitive Feasibility Study
|
|
tonks306511
|
46 |
24K |
0 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
46
|
24K
|
0
|
|
ASX - By Stock
|
DYL |
Re:
Ann: Strong Results From Tumas Definitive Feasibility Study
|
|
tonks306511
|
46 |
24K |
0 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
46
|
24K
|
0
|
|
ASX - By Stock
|
DYL |
Re:
Ann: Strong Results From Tumas Definitive Feasibility Study
|
|
tonks306511
|
46 |
24K |
3 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
46
|
24K
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
tonks306511
|
11K |
3.8M |
0 |
01/02/23 |
01/02/23 |
General
|
11K
|
3.8M
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
tonks306511
|
56 |
15K |
2 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
56
|
15K
|
2
|
|
ASX - By Stock
|
PH2 |
Re:
Ann: December 2022 Quarterly Report
|
|
tonks306511
|
4 |
2.5K |
8 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
4
|
2.5K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
tonks306511
|
56 |
15K |
27 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
56
|
15K
|
27
|
|
ASX - By Stock
|
HIO |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
tonks306511
|
11 |
4.9K |
4 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
11
|
4.9K
|
4
|
|
ASX - By Stock
|
DYL |
Re:
Uranium the next Lithium
|
|
tonks306511
|
19 |
10K |
5 |
27/01/23 |
27/01/23 |
ASX - By Stock
|
19
|
10K
|
5
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
tonks306511
|
11K |
3.8M |
9 |
24/01/23 |
24/01/23 |
General
|
11K
|
3.8M
|
9
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
tonks306511
|
11K |
3.8M |
3 |
22/01/23 |
22/01/23 |
General
|
11K
|
3.8M
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Letter to Shareholders, Notice of Meeting & Proxy Form
|
|
tonks306511
|
41 |
13K |
25 |
20/01/23 |
20/01/23 |
ASX - By Stock
|
41
|
13K
|
25
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Letter to Shareholders, Notice of Meeting & Proxy Form
|
|
tonks306511
|
41 |
13K |
25 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
41
|
13K
|
25
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Letter to Shareholders, Notice of Meeting & Proxy Form
|
|
tonks306511
|
41 |
13K |
12 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
41
|
13K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 3Y - Dr Daniel Tillett
|
|
tonks306511
|
46 |
16K |
22 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
46
|
16K
|
22
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
tonks306511
|
1.8K |
635K |
7 |
09/01/23 |
09/01/23 |
ASX - By Stock
|
1.8K
|
635K
|
7
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
21K |
7.4M |
26 |
08/01/23 |
08/01/23 |
ASX - By Stock
|
21K
|
7.4M
|
26
|
|
ASX - By Stock
|
PV1 |
Re:
Provaris - Media
|
|
tonks306511
|
163 |
80K |
3 |
05/01/23 |
05/01/23 |
ASX - By Stock
|
163
|
80K
|
3
|
|
ASX - By Stock
|
HIO |
Re:
Price and Chart HIO
|
|
tonks306511
|
7.3K |
3.0M |
4 |
02/01/23 |
02/01/23 |
ASX - By Stock
|
7.3K
|
3.0M
|
4
|
|
ASX - By Stock
|
PV1 |
Re:
Provaris - Media
|
|
tonks306511
|
163 |
80K |
0 |
30/12/22 |
30/12/22 |
ASX - By Stock
|
163
|
80K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race supports Study of Extramedullary AML
|
|
tonks306511
|
50 |
20K |
2 |
24/12/22 |
24/12/22 |
ASX - By Stock
|
50
|
20K
|
2
|
|
ASX - By Stock
|
PV1 |
Re:
Provaris - Media
|
|
tonks306511
|
163 |
80K |
3 |
20/12/22 |
20/12/22 |
ASX - By Stock
|
163
|
80K
|
3
|
|
ASX - By Stock
|
PV1 |
Re:
Provaris - Media
|
|
tonks306511
|
163 |
80K |
3 |
17/12/22 |
17/12/22 |
ASX - By Stock
|
163
|
80K
|
3
|
|
ASX - By Stock
|
HIO |
Re:
Granzien focus or 1 foot out the door?
|
|
tonks306511
|
43 |
17K |
2 |
16/12/22 |
16/12/22 |
ASX - By Stock
|
43
|
17K
|
2
|
|
ASX - By Stock
|
PH2 |
Re:
Australian Hydrogen Conference 2022
|
|
tonks306511
|
27 |
9.6K |
1 |
13/12/22 |
13/12/22 |
ASX - By Stock
|
27
|
9.6K
|
1
|
|
ASX - By Stock
|
DYL |
Re:
Ann: Results of Annual General Meeting
|
|
tonks306511
|
11 |
5.7K |
1 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
11
|
5.7K
|
1
|
|
ASX - By Stock
|
DYL |
Re:
Ann: Results of Annual General Meeting
|
|
tonks306511
|
11 |
5.7K |
0 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
11
|
5.7K
|
0
|
|
ASX - By Stock
|
DYL |
Re:
Ann: Results of Annual General Meeting
|
|
tonks306511
|
11 |
5.7K |
0 |
28/11/22 |
28/11/22 |
ASX - By Stock
|
11
|
5.7K
|
0
|
|
ASX - By Stock
|
HIO |
Re:
Ann: Hawsons Institutional Placement
|
|
tonks306511
|
189 |
73K |
7 |
28/11/22 |
28/11/22 |
ASX - By Stock
|
189
|
73K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race 2022 AGM Presentations
|
|
tonks306511
|
118 |
32K |
5 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
118
|
32K
|
5
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
tonks306511
|
11K |
3.8M |
8 |
22/11/22 |
22/11/22 |
General
|
11K
|
3.8M
|
8
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
21K |
7.4M |
19 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
21K
|
7.4M
|
19
|
|
ASX - By Stock
|
PER |
Re:
NOW I UNDERSTAND MARK
|
|
tonks306511
|
15 |
6.1K |
6 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
15
|
6.1K
|
6
|
|